Federal Lobbyist Spending to Influence 340B Drug Pricing Program Policy
JAMA Network Open · 04.06.2026 · 9 (6) · e2616602
DOI: 10.1001/jamanetworkopen.2026.16602 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 04.06.2026. Verfasst von Cooper Urban und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health, New York University Grossman School of Medicine, New York. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This cross-sectional study identifies organizations engaged in lobbying related to the 340B Drug Pricing Program, estimates their lobbying expenditures, and characterizes their policy priorities.
Autor:innen und Institutionen
- Department of Population Health, New York University Grossman School of Medicine, New York.
Zitieren
APA
Urban, C., Shore, C., Desai, S., & Taylor, L. (2026). Federal Lobbyist Spending to Influence 340B Drug Pricing Program Policy. JAMA Network Open, 9(6), e2616602. https://doi.org/10.1001/jamanetworkopen.2026.16602
Vancouver
Urban C, Shore C, Desai S, Taylor L. Federal Lobbyist Spending to Influence 340B Drug Pricing Program Policy. JAMA Network Open. 2026;9(6):e2616602. doi:10.1001/jamanetworkopen.2026.16602
BibTeX
@article{Urban2026,
author = {Urban, Cooper and Shore, Caroline and Desai, Sunita and Taylor, Lauren},
title = {Federal Lobbyist Spending to Influence 340B Drug Pricing Program Policy},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {6},
pages = {e2616602},
doi = {10.1001/jamanetworkopen.2026.16602}
}
EUVIMED